Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("serotonin")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 31806

  • Page / 1273
Export

Selection :

  • and

Serotonin syndrome induced by low-dose venlafaxinePAN, Jan-Jhy; SHEN, Winston W.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 209-211, issn 1060-0280, 3 p.Article

Avoiding Serotonin Syndrome: The Nature of the Interaction Between Tramadol and Selective Serotonin Reuptake InhibitorsNELSON, Elana M; PHILBRICK, Ann M.The Annals of pharmacotherapy. 2012, Vol 46, Num 12, pp 1712-1716, issn 1060-0280, 5 p.Article

Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?MARAZZITI, D; BARONI, S; DELL'OSSO, M. Catena et al.Current medicinal chemistry. 2011, Vol 18, Num 18, pp 2783-2790, issn 0929-8673, 8 p.Article

A reduced extracellular serotonin level increases the 5-HT1APET ligand 18F-MPPF binding in the rat hippocampusZIMMER, Luc; RBAH, Latifa; GIACOMELLI, Fabrice et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 9, pp 1495-1501, issn 0161-5505, 7 p.Article

Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor TreatmentVAN GEFFEN, Erica C. G; VAN HULTEN, Rolf; BOUVY, Marcel L et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 2, pp 218-225, issn 1060-0280, 8 p.Article

Ethanol self-administration in serotonin transporter knockout mice: unconstrained demand and elasticityLAMB, R. J; DAWS, L. C.Genes, brain and behavior (Print). 2013, Vol 12, Num 7, pp 741-747, issn 1601-1848, 7 p.Article

Serotonin Syndrome Risks When Combining SSRI/SNRI Drugs and Triptans : Is the FDA's Alert Warranted?WENZEL, Richard G; TEPPER, Stewart; KORAB, William E et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 11, pp 1692-1696, issn 1060-0280, 5 p.Article

What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?DEMYTTENAERE, Koen; ALBERT, Adelin; MESTERS, Patrick et al.The Journal of clinical psychiatry. 2005, Vol 66, Num 7, pp 859-863, issn 0160-6689, 5 p.Article

Ninety-three cases of alcohol dependence following SSRI treatmentBROOKWELL, Louise; HOGAN, Carys; HEALY, David et al.International journal of risk & safety in medicine. 2014, Vol 26, Num 2, pp 99-107, issn 0924-6479, 9 p.Article

The risk of suicide with selective serotonin reuptake inhibitors in the elderlyJUURLINK, David N; MAMDANI, Muhammad M; KOPP, Alexander et al.The American journal of psychiatry. 2006, Vol 163, Num 5, pp 813-821, issn 0002-953X, 9 p.Article

Facilitation of Serotonin Signaling by SSRIs is Attenuated by Social IsolationDANKOSKI, Elyse C; AGSTER, Kara L; FOX, Megan E et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 13, pp 2928-2937, issn 0893-133X, 10 p.Article

Discontinuation of Maintenance Selective Serotonin Reuptake Inhibitor Monotherapy After 5 Years of Stable Response : A Naturalistic StudyPUNDIAK, Tara M; CASE, Brady G; PESELOW, Eric D et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 11, pp 1811-1817, issn 0160-6689, 7 p.Article

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice : tapering versus abrupt discontinuationVAN GEFFEN, E. C. G; HUGTENBURG, J. G; HEERDINK, E. R et al.European journal of clinical pharmacology. 2005, Vol 61, Num 4, pp 303-307, issn 0031-6970, 5 p.Article

Inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) et ostéoporose : Ostéoporose = Selective serotonin reuptake inhibitors (SSRI) and osteoporosisFETIQUE-WILL, A.-C; CHEVALLEY, T; RIZZOLI, R et al.Revue médicale suisse. 2011, Vol 7, Num 299, pp 1299-1304, issn 1660-9379, 6 p.Article

How often do ssris and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is lowZIMMERMAN, Mark; THONGY, Tavi.The Journal of clinical psychiatry. 2007, Vol 68, Num 8, pp 1271-1276, issn 0160-6689, 6 p.Article

THE IMPACT OF ENVIRONMENTAL ENRICHMENT ON SEX-SPECIFIC NEUROCHEMICAL CIRCUITRIES: EFFECTS ON BRAIN-DERIVED NEUROTROPHIC FACTOR AND THE SEROTONERGIC SYSTEMCHOURBAJI, S; HÖRTNAGL, H; MOLTENI, R et al.Neuroscience. 2012, Vol 220, pp 267-276, issn 0306-4522, 10 p.Article

Plasma serotonin levels and the platelet serotonin transporterBRENNER, B; HAMEY, J. T; AHMED, B. A et al.Journal of neurochemistry. 2007, Vol 102, Num 1, pp 206-215, issn 0022-3042, 10 p.Article

Serotonin syndrome caused by interaction between citalopram and fentanylAILAWADHI, S; SUNG, K.-W; CARLSON, L. A et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 2, pp 199-202, issn 0269-4727, 4 p.Article

Citalopram modulation of neuronal responses to aversive face emotions : a functional MRI studyANDERSON, Lan M; DEL-BEN, Cristina M; MCKIE, Shane et al.Neuroreport (Oxford). 2007, Vol 18, Num 13, pp 1351-1355, issn 0959-4965, 5 p.Article

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopramKASPER, Siegfried; SACHER, Julia; KLEIN, Nikolas et al.International clinical psychopharmacology. 2009, Vol 24, Num 3, pp 119-125, issn 0268-1315, 7 p.Article

Effects of 5-HT6 receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the ratDAWSON, L. A; LI, P.Journal of neural transmission. 2003, Vol 110, Num 6, pp 577-590, issn 0300-9564, 14 p.Article

R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation modelSANCHEZ, Connie.European journal of pharmacology. 2003, Vol 464, Num 2-3, pp 155-158, issn 0014-2999, 4 p.Article

Selective Serotonin Reuptake Inhibitors for the Treatment of Irritable Bowel SyndromeBUNDEFF, Andrew W; WOODIS, C. Brock.The Annals of pharmacotherapy. 2014, Vol 48, Num 6, pp 777-784, issn 1060-0280, 8 p.Article

Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization testKASSAI, Ferenc; GYERTYAN, István.Progress in neuro-psychopharmacology & biological psychiatry. 2012, Vol 36, Num 1, pp 128-135, issn 0278-5846, 8 p.Article

Patients' perceptions of information received at the start of selective serotonin-reuptake inhibitor treatment : Implications for community pharmacyVAN GEFFEN, Erica C. G; KRUIJTBOSCH, Martine; EGBERTS, Antoine C. G et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 4, pp 642-649, issn 1060-0280, 8 p.Article

  • Page / 1273